🇺🇸 FDA
Pipeline program

TNX-201

TNX-IS-T201

Phase 2 small_molecule completed

Quick answer

TNX-201 for Tension-Type Headache is a Phase 2 program (small_molecule) at Tonix Pharmaceuticals Holding with 1 ClinicalTrials.gov record(s).

Program details

Company
Tonix Pharmaceuticals Holding
Indication
Tension-Type Headache
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials